Stockreport

Evommune Announces $125 Million Private Placement

Evommune, Inc.  (EVMN) 
PDF PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (“Evommune” or the “Company”) (NYSE: EVMN), a clinical-stage biotechnology company developing innovativ [Read more]